Pacific Biosciences of California
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $39,967 | $36,013 | $38,810 | $58,357 |
Gross Profit | 10,004 | 5,938 | 4,429 | 11,004 |
EBITDA | -59,258 | -155,488 | -62,589 | -61,309 |
EBIT | -75,357 | -169,777 | -74,603 | -79,165 |
Net Income | -60,725 | -173,319 | -78,178 | -82,018 |
Net Change In Cash | 39,967 | 36,013 | 38,810 | 58,357 |
Free Cash Flow | -44,676 | -55,742 | -79,561 | -59,634 |
Cash | 77,982 | 99,526 | 76,946 | 180,211 |
Basic Shares | 272,915 | 272,385 | 269,578 | 267,120 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $200,521 | $128,304 | $130,513 | $78,893 |
Gross Profit | 52,780 | 49,035 | 58,860 | 32,566 |
EBITDA | -277,282 | -282,240 | -250,757 | 38,974 |
EBIT | -303,816 | -299,558 | -262,342 | 29,670 |
Net Income | -306,735 | -296,930 | -181,223 | 29,403 |
Net Change In Cash | 200,521 | 128,304 | 130,513 | 78,893 |
Cost of Revenue | 379,870 | 52,020 | ||
Free Cash Flow | -268,016 | -280,140 | -117,111 | 18,464 |
Cash | 180,211 | 325,089 | 460,725 | 318,814 |
Basic Shares | 253,629 | 224,550 | 204,136 | 174,970 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.22 |
2024-06-30 | -$0.64 |
2024-03-31 | -$0.29 |
2023-12-31 | -$0.31 |
